Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.3975
-0.0030 (-0.75%)
At close: Feb 20, 2026, 4:00 PM EST
0.3531
-0.0444 (-11.17%)
Pre-market: Feb 23, 2026, 8:19 AM EST
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $1.44 million as of February 23, 2026. Its market cap has decreased by -82.13% in one year.
Market Cap
1.44M
Enterprise Value
158.33K
1-Year Change
-82.13%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $1.44M, a decrease of -100.00%. That is a compound annual growth rate of -73.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.44M | -56.79% |
| Dec 31, 2025 | 3.34M | -68.54% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scinai Immunotherapeutics | 2.50M |
| Bone Biologics | 2.15M |
| Clearmind Medicine | 2.10M |
| CNS Pharmaceuticals | 1.99M |
| Azitra | 1.80M |
| CDT Equity | 1.73M |
| Virax Biolabs Group | 1.58M |
| Abpro Holdings | 1.42M |